Cole is a senior scientist in the Platform Development group focused on enabling high-throughput antibody discovery. Prior to joining Cartography, he worked in the lab of Jim Wells where he developed novel single-domain antibody libraries for use as immunotherapies and antivirals. He holds a Ph.D. in Chemistry and Chemical Biology from UCSF. In his free time, Cole enjoys rock climbing, racing marathons, and reading comics
Recent Posts
- Cartography Announces Strategic Collaboration with Gilead to Develop Oncology Therapies Against Novel Targets and Target Pairs
- Cartography Biosciences Expands Leadership Team with Appointment of Dan Rock, Ph.D., as Chief Scientific Officer to Advance Novel Oncology Programs into Clinic
- Cartography Biosciences and Nested Therapeutics: Diamonds in the rough
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts
- Cartography Biosciences Co-Founder and Chief Executive Officer Kevin Parker, Ph.D., Earns Spot on Endpoints News’ 20 Under 40 List
Recent Comments
No comments to show.